Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AEGIR.ST Stock Summary
In the News
AEGIR.ST Financial details
Company Rating
Neutral
Market Cap
20.75M
Income
-368.57M
Revenue
99K
Book val./share
0.29
Cash/share
0.91
Dividend
-
Dividend %
-
Employees
14
Optionable
No
Shortable
Yes
Earnings
27 Aug 2020
P/E
-0.05
Forward P/E
-
PEG
-0
P/S
311.89
P/B
2.52
P/C
0.61
P/FCF
-0.62
Quick Ratio
2.12
Current Ratio
2.53
Debt / Equity
4.58
LT Debt / Equity
4.49
-
-
EPS (TTM)
-17.06
EPS next Y
-
EPS next Q
-
EPS this Y
235.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
3500%
EPS Q/Q
2.99%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-569%
ROE
-904%
ROC
-6.83%
Gross Margin
-24399%
Oper. Margin
-370291%
Profit Margin
-372297%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.5-2.198
52W High
-
52W Low
-
RSI
28
Rel Volume
2.26
Avg Volume
117.77K
Volume
265.77K
Perf Week
-18.39%
Perf Month
-20.14%
Perf Quarter
-32.24%
Perf Half Y
-44.07%
-
-
-
-
Beta
2.573
-
-
Volatility
0.05%, 0.04%
Prev Close
-8.36%
Price
0.559
Change
-9.4%
AEGIR.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0.81 | 0.09 | |
Net income per share | 0 | -0.89 | -5.64 | -18.9 | |
Operating cash flow per share | 0 | -0.63 | -6.68 | -2.55 | |
Free cash flow per share | 0 | -0.64 | -6.68 | -2.56 | |
Cash per share | 0 | 0.89 | 2.08 | 0.76 | |
Book value per share | 0 | 3.33 | 22.61 | 2.07 | |
Tangible book value per share | 0 | 0.63 | 2.26 | -0.25 | |
Share holders equity per share | 0 | 3.33 | 22.61 | 2.07 | |
Interest debt per share | 0 | 0.06 | 0.86 | 0.38 | |
Market cap | 0 | 253.21M | 935.33M | 38.61M | |
Enterprise value | -49.94K | 243.51M | 911.13M | 31.18M | |
P/E ratio | 0 | -24.47 | -10.13 | -0.11 | |
Price to sales ratio | 0 | 0 | 70.42 | 22.63 | |
POCF ratio | 0 | -34.19 | -8.55 | -0.79 | |
PFCF ratio | 0 | -33.75 | -8.55 | -0.79 | |
P/B Ratio | 0 | 6.51 | 2.53 | 0.97 | |
PTB ratio | 0 | 6.51 | 2.53 | 0.97 | |
EV to sales | 0 | 0 | 68.6 | 18.28 | |
Enterprise value over EBITDA | 201.36 | -23.53 | -10.59 | -0.09 | |
EV to operating cash flow | 201.36 | -32.88 | -8.33 | -0.64 | |
EV to free cash flow | 201.36 | -32.45 | -8.33 | -0.64 | |
Earnings yield | 0 | -0.04 | -0.1 | -9.4 | |
Free cash flow yield | 0 | -0.03 | -0.12 | -1.27 | |
Debt to equity | 0 | 0.02 | 0.03 | 0.18 | |
Debt to assets | 0 | 0.02 | 0.02 | 0.11 | |
Net debt to EBITDA | 201.36 | 0.94 | 0.28 | 0.02 | |
Current ratio | 1.5 | 2.73 | 3.67 | 1.11 | |
Interest coverage | 0 | 0 | -19.01 | -1.67K | |
Income quality | 1 | 0.72 | 1.36 | 0.13 | |
Dividend Yield | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 1.46 | 11.68 | |
Research and developement to revenue | 0 | 0 | 3.87 | 23.04 | |
Intangibles to total assets | 0.84 | 0.71 | 0.82 | 0.67 | |
Capex to operating cash flow | 0 | 0.01 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | -0.04 | |
Capex to depreciation | 0 | 0 | 0 | -0.01 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | |
Graham number | 0 | 8.14 | 53.55 | 29.7 | |
ROIC | 0 | 1.28 | -0.21 | -7.44 | |
Return on tangible assets | 0 | -0.82 | -1.3 | -16.26 | |
Graham Net | 0 | 0.44 | 1.16 | -0.49 | |
Working capital | 49.94K | 7.94M | 49.6M | 1.93M | |
Tangible asset value | 49.94K | 7.34M | 37.09M | -4.73M | |
Net current asset value | 49.94K | 7.25M | 34.25M | -7.84M | |
Invested capital | 0 | 0.02 | 0.03 | 0.18 | |
Average receivables | 0 | 50.06K | 4.31M | 6.32M | |
Average payables | 0 | 1.94M | 5.01M | 5.53M | |
Average inventory | 0 | 500 | 12.45M | 12.45M | |
Days sales outstanding | 0 | 0 | 236.86 | 859.44 | |
Days payables outstanding | 0 | 0 | 292.96 | 69.3 | |
Days of inventory on hand | 0 | 0 | 1.17K | 0 | |
Receivables turnover | 0 | 0 | 1.54 | 0.42 | |
Payables turnover | 0 | 0 | 1.25 | 5.27 | |
Inventory turnover | 0 | 0 | 0.31 | 0 | |
ROE | 0 | -0.27 | -0.25 | -9.11 | |
Capex per share | 0 | -0.01 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0 | 0 | 0 | 0 | |
Net income per share | -0.64 | -14.94 | -0.76 | -0.67 | -0.69 | |
Operating cash flow per share | -0.5 | -0.55 | -0.63 | -0.47 | -0.51 | |
Free cash flow per share | -0.5 | -0.55 | -0.63 | -0.47 | -0.51 | |
Cash per share | 1.34 | 0.69 | 2.03 | 1.53 | 0.91 | |
Book value per share | 17.07 | 1.87 | 4.11 | 1.07 | 0.29 | |
Tangible book value per share | 1.62 | -0.22 | 4.11 | -0.58 | 0.29 | |
Share holders equity per share | 17.07 | 1.87 | 4.11 | 1.07 | 0.29 | |
Interest debt per share | 0.14 | 0.34 | 0.12 | 1.47 | 1.63 | |
Market cap | 108.85M | 42.8M | 68.99M | 34.44M | 31.57M | |
Enterprise value | 83.56M | 35.37M | 26.9M | 30.63M | 42.47M | |
P/E ratio | -2.03 | -0.03 | -1.03 | -0.54 | -0.44 | |
Price to sales ratio | 351.13 | 7.13K | 1.23K | 34.44K | 876.94 | |
POCF ratio | -10.38 | -3.66 | -5.02 | -3.06 | -2.4 | |
PFCF ratio | -10.34 | -3.65 | -5.02 | -3.04 | -2.4 | |
P/B Ratio | 0.3 | 1.07 | 0.76 | 1.35 | 4.21 | |
PTB ratio | 0.3 | 1.07 | 0.76 | 1.35 | 4.21 | |
EV to sales | 269.56 | 5.89K | 480.38 | 30.63K | 1.18K | |
Enterprise value over EBITDA | -6.09 | -0.11 | -1.58 | -2.18 | -4.05 | |
EV to operating cash flow | -7.97 | -3.02 | -1.96 | -2.72 | -3.23 | |
EV to free cash flow | -7.94 | -3.02 | -1.96 | -2.71 | -3.23 | |
Earnings yield | -0.12 | -7.43 | -0.24 | -0.46 | -0.57 | |
Free cash flow yield | -0.1 | -0.27 | -0.2 | -0.33 | -0.42 | |
Debt to equity | 0.01 | 0.18 | 0.03 | 1.28 | 4.58 | |
Debt to assets | 0.01 | 0.11 | 0.02 | 0.4 | 0.53 | |
Net debt to EBITDA | 1.84 | 0.02 | 2.47 | 0.27 | -1.04 | |
Current ratio | 4.81 | 1.11 | 7.86 | 3.73 | 2.53 | |
Interest coverage | -162.54 | -10.28K | -200.53 | -6.1 | -2.15 | |
Income quality | 0.74 | 0.04 | 0.79 | 0.8 | 0.78 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 14.7 | 754.67 | 111.75 | 4.19K | 59.06 | |
Research and developement to revenue | 29.49 | 1.96K | 168.68 | 9.71K | 425.31 | |
Intangibles to total assets | 0.84 | 0.67 | 0 | 0.48 | 0.54 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.15 | -3.33 | 0 | -44 | -0.03 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 15.68 | 25.08 | 8.4 | 4.01 | 2.12 | |
ROIC | -0.04 | -6.51 | -0.18 | -0.23 | -0.39 | |
Return on tangible assets | -0.22 | -14.25 | -0.13 | -0.38 | -0.6 | |
Graham Net | 0.8 | -0.44 | 0.35 | -0.67 | -1.17 | |
Working capital | 45.4M | 1.93M | 44.36M | 29.98M | 16.98M | |
Tangible asset value | 33.97M | -4.73M | 90.27M | -13.82M | -27.25M | |
Net current asset value | 30.08M | -7.84M | 9.31M | -14.97M | -29.19M | |
Invested capital | 0.01 | 0.18 | 0.03 | 1.28 | 4.58 | |
Average receivables | 25.58M | 4.5M | 5.1M | 5.27M | 4.48M | |
Average payables | 14.93M | 7.3M | 4.55M | 7.15M | 10.19M | |
Average inventory | 24.21M | 12.1M | 0 | 0 | 0 | |
Days sales outstanding | 1.44K | 60.26K | 9.92K | 391.95K | 11.53K | |
Days payables outstanding | 2.39K | 17.94 | 2.75K | -9.8K | 0 | |
Days of inventory on hand | 5.92K | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.06 | 0 | 0.01 | 0 | 0.01 | |
Payables turnover | 0.04 | 5.02 | 0.03 | -0.01 | 0 | |
Inventory turnover | 0.02 | 0 | 18790.48B | 0 | 0 | |
ROE | -0.04 | -7.98 | -0.19 | -0.63 | -2.39 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
AEGIR.ST Frequently Asked Questions
What is AegirBio AB (publ) stock symbol ?
AegirBio AB (publ) is a SE stock and trading under the symbol AEGIR.ST
What is AegirBio AB (publ) stock quote today ?
AegirBio AB (publ) stock price is $0.559 today.
Is AegirBio AB (publ) stock public?
Yes, AegirBio AB (publ) is a publicly traded company.